Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 26 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Dimopoulos, Meletios A [Clear All Filters]
Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer..
Clin Breast Cancer. 14(5), 330-8.
(2014).
(2016).
Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017).
(2018).
(2018).
Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study..
Blood. 126(11), 1392-4.
(2015).
(2012).
(2014). Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis..
Blood Cancer J. 8(5), 46.
(2018).
(2013). Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017). Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer..
Carcinogenesis. 35(5), 1012-9.
(2014). Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis..
Blood. 131(14), 1568-1575.
(2018). Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017). Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant..
Amyloid. 26(1), 52-53.
(2019). How We Manage Patients with Plasmacytomas..
Curr Hematol Malig Rep. 13(3), 227-235.
(2018). Managing renal complications in multiple myeloma..
Expert Rev Hematol. 9(9), 839-50.
(2016). Myocardial adrenergic denervation in patients with primary (AL) amyloidosis..
Amyloid. 10(2), 117-20.
(2003). Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial..
Breast Cancer Res Treat. 132(2), 609-19.
(2012). Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases..
PLoS One. 8(3), e58182.
(2013).
(2013).
(2010).
(2011).
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group..
Blood Cancer J. 8(3), 31.
(2018). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017).